Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha

Cancer is one of the main causes of human mortality worldwide and novel chemotherapeutics are required due to the limitations of conventional cancer therapies. For example, using redox selenium compounds as novel chemotherapeutics seem to be very promising. The objective of this study was to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Razaghi, Ali, Zickler, Antje Maria, Spallholz, Julian, Kirsch, Gilbert, Björnstedt, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209087/
https://www.ncbi.nlm.nih.gov/pubmed/34169173
http://dx.doi.org/10.1016/j.heliyon.2021.e07254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209087/
https://www.ncbi.nlm.nih.gov/pubmed/34169173
http://dx.doi.org/10.1016/j.heliyon.2021.e07254

Ejemplares similares